Oncura Innovations Private Limited

Oncura Innovations Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2022PTC396013 Incorporated 27 December 2022 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹46.97 Cr
▲ 157% YoY
Net profit · FY 2025
₹1.01 Cr
Net margin 2.2%
EBITDA · FY 2025
₹1.96 Cr
EBITDA margin 4.2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹35 Lakh
Issued & subscribed
Open charges
₹8.6 Cr
Satisfied ₹2.25 Cr
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings

About Oncura Innovations Private Limited

Data last updated:

Oncura Innovations Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 December 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2022PTC396013. Its GSTIN is 27AALCB3091L1ZA (Maharashtra).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹35 Lakh. It was formerly known as Biotric Pharma Private Limited. It is led by directors Aditya Ashok Vaishya and Arun Ashok Vaishya.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1042 M Wing 1st Floor Akshar Business Park, Sector 25, Thane, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹46.97 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.01 Cr (net margin 2.2%) and EBITDA of ₹1.96 Cr (EBITDA margin 4.2%).

As per MCA filings, the company has open charges of ₹8.6 Cr and satisfied charges of ₹2.25 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909MH2022PTC396013
Registration Number 396013
Incorporation Date 27 December 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Oncura Innovations Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Unit No. 1042 M Wing 1st Floor Akshar Business Park, Plot No.3 Sector 25 Vashi, Thane, Maharashtra, India – 400703
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Oncura Innovations Private Limited, buy the company report.

Comprehensive company report
Oncura Innovations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Oncura Innovations is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Oncura Innovations Private Limited, buy the company report.

Financials of Oncura Innovations Private Limited

FY 2025 filings available

Oncura Innovations Private Limited reported revenue of ₹46.97 Cr (up 157% YoY) for FY 2025.

Revenue · FY 2025
₹46.97 Cr ▲ 157%
Net profit · FY 2025
₹1.01 Cr margin 2.2%
EBITDA · FY 2025
₹1.96 Cr margin 4.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 157%
EBITDA CAGR growth
1 year
▲ 186%

Revenue rose 157% in the latest year. EBITDA rose 186% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.96 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.01 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin4.2%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Oncura Innovations Private Limited, buy the company report.

Board of directors of Oncura Innovations Private Limited

Oncura Innovations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aditya Ashok VaishyaDirector27 Dec 20223 Years 10 MonthsCurrent
Arun Ashok VaishyaDirector27 Dec 20223 Years 10 MonthsCurrent

Auditor

Oncura Innovations Private Limited is audited by V. B. WAGHMARE & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
V. B. WAGHMARE & CO.FY 2023154191

Shareholding

The shareholding of Oncura Innovations Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Oncura Innovations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.6 Cr
Satisfied charges
₹2.25 Cr
Breakdown by lending institutions
Others₹5.00 Cr
Standard Chartered Bank₹3.60 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Feb 2025101097420Standard Chartered Bank₹3.6 CrOpen
19 Sep 2024100992627Others₹5 CrOpen
05 Jan 2024100844624Others₹2.25 CrSatisfied

To see the full charge records of Oncura Innovations Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Oncura Innovations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Oncura Innovations Private Limited has 1 active EPFO establishment as of Apr 07, 2024.

Active EPFO establishments
1

GST

Oncura Innovations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AALCB3091L1ZAMaharashtraActive09 Jan 2023

To see the full GST registrations and return filing status of Oncura Innovations Private Limited, buy the company report.

Recent activity

Oncura Innovations Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Sandhya Ashok Vaishya ceased to be Additional Director on 28 Jan 2025.

AGM
Oncura Innovations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oncura Innovations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge registered on 05 Jan 2024 via Charge ID 100844624 with Others was fully satisfied on 17 Mar 2025.
Charges
A charge with Standard Chartered Bank amounted to Rs. 360.00 Lakh with Charge ID 101097420 was registered on 26 Feb 2025.
Ceased
Sandhya Ashok Vaishya ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100992627 was registered on 19 Sep 2024.
Charges
A charge with Others amounted to Rs. 225.00 Lakh with Charge ID 100844624 was registered on 05 Jan 2024.
Ceased
Abhinav Govind Tripathi ceased to be Director.
Appointed
Aditya Ashok Vaishya was appointed as Director.
Appointed
Arun Ashok Vaishya was appointed as Director.
Incorporation
27 Dec 2022
Oncura Innovations Private Limited was registered on 27 Dec 2022 with Roc Mumbai Ii & aged 3 years 10 months as per MCA records.

Frequently asked questions

Oncura Innovations is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 December 2022 (4+ years old) and is registered under CIN U51909MH2022PTC396013.

Oncura Innovations has 2 current directors:

The latest financial statements of Oncura Innovations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Oncura Innovations is 27AALCB3091L1ZA, registered in Maharashtra.

The CIN (Corporate Identification Number) of Oncura Innovations is U51909MH2022PTC396013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Oncura Innovations was incorporated on 27 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Sandhya Ashok Vaishya ceased to be Additional Director on 28 Jan 2025. Abhinav Govind Tripathi ceased to be Director on 08 Nov 2023. Aditya Ashok Vaishya was appointed as Director on 27 Dec 2022. Oncura Innovations has 4 board changes on record in total.

The registered office of Oncura Innovations is at Unit No. 1042 M Wing 1st Floor Akshar Business Park, Plot No.3 Sector 25 Vashi, Thane, Maharashtra, India – 400703.

Oncura Innovations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Oncura Innovations has open charges of ₹8.6 Cr and satisfied charges of ₹2.25 Cr as per latest MCA filings.